Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Uncategorized
    • Dr. Reddy’s...

    Dr. Reddy’s Laboratories and T Pharm Biosimilar giants come together in Turkey

    Written by savita thakur thakur Published On 2016-03-14T11:24:46+05:30  |  Updated On 14 March 2016 11:24 AM IST
    Mumbai : A strategic collaboration has been worked out in between Dr. Reddy’s Laboratories and TR-Pharm to manufacture and commercialize a portfolio of biosimilar drugs in Turkey.

    According to this agreement , a total of three products have been registered as subsequently commercialized, by TR-Pharm in Turkey. On completion of its facility investment TR-Pharm will be manufacturing the drug substance and drug product in it.

    According to IFFL, Dr Reddys Laboratories Ltd is currently trading at Rs. 3202, up by Rs. 17.75 or 0.56% from its previous closing of Rs. 3184.25 on the BSE.

    The scrip opened at Rs. 3175 and has touched a high and low of Rs. 3223.35 and Rs. 3175 respectively. So far 145749 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 54325.74 crore.

    The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750 on 21-Jan-2016. Last one week high and low of the scrip stood at Rs. 3280 and Rs. 3163.5 respectively.

    The promoters holding in the company stood at 25.57 % while Institutions and Non-Institutions held 43.5 % and 30.93 % respectively.

    The stock is currently trading below its 200 DMA.

    biosimilarsDr Reddy'sTR-Pharm
    Source : IIFL

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok